We performed immunohistochemistry analyses to detect the endothelial marker PECAM/CD31, which highlighted a marked reduction in the vascularization of HIF2α(1–485) expressing tumours and an amplification of angiogenesis in HIF2α ones (Fig. 6a). This evidence concerns the gene PECAM1 and neoplasm.